Oncogenic PI3K deregulates transcription and translation
- PMID: 16341083
- DOI: 10.1038/nrc1753
Oncogenic PI3K deregulates transcription and translation
Abstract
There have long been indications of a role for PI3K (phosphatidylinositol 3-kinase) in cancer pathogenesis. Experimental data document a requirement for deregulation of both transcription and translation in PI3K-mediated oncogenic transformation. The recent discoveries of cancer-specific mutations in PIK3CA, the gene that encodes the catalytic subunit p110alpha of PI3K, have heightened the interest in the oncogenic potential of this lipid kinase and have made p110alpha an ideal drug target.
Similar articles
-
Effects of oncogenic p110alpha subunit mutations on the lipid kinase activity of phosphoinositide 3-kinase.Biochem J. 2008 Jan 15;409(2):519-24. doi: 10.1042/BJ20070681. Biochem J. 2008. PMID: 17877460
-
The structure of a human p110alpha/p85alpha complex elucidates the effects of oncogenic PI3Kalpha mutations.Science. 2007 Dec 14;318(5857):1744-8. doi: 10.1126/science.1150799. Science. 2007. PMID: 18079394
-
Oncogenic mutations of the PIK3CA gene in head and neck squamous cell carcinomas.Int J Oncol. 2008 Jan;32(1):101-11. Int J Oncol. 2008. PMID: 18097548
-
Phosphoinositide 3-kinase: from viral oncoprotein to drug target.Virology. 2006 Jan 5;344(1):131-8. doi: 10.1016/j.virol.2005.09.027. Virology. 2006. PMID: 16364744 Review.
-
Cancer-specific mutations in phosphatidylinositol 3-kinase.Trends Biochem Sci. 2007 Jul;32(7):342-9. doi: 10.1016/j.tibs.2007.05.005. Epub 2007 Jun 11. Trends Biochem Sci. 2007. PMID: 17561399 Review.
Cited by
-
Targeting PI3K family with small-molecule inhibitors in cancer therapy: current clinical status and future directions.Mol Cancer. 2024 Aug 10;23(1):164. doi: 10.1186/s12943-024-02072-1. Mol Cancer. 2024. PMID: 39127670 Free PMC article. Review.
-
DDX19A promotes gastric cancer cell proliferation and migration by activating the PI3K/AKT pathway.Cancer Cell Int. 2024 Aug 3;24(1):272. doi: 10.1186/s12935-024-03448-5. Cancer Cell Int. 2024. PMID: 39097730 Free PMC article.
-
TSP50 facilitates breast cancer stem cell-like properties maintenance and epithelial-mesenchymal transition via PI3K p110α mediated activation of AKT signaling pathway.J Exp Clin Cancer Res. 2024 Jul 20;43(1):201. doi: 10.1186/s13046-024-03118-4. J Exp Clin Cancer Res. 2024. PMID: 39030572 Free PMC article.
-
PI3Kγ in B cells promotes antibody responses and generation of antibody-secreting cells.Nat Immunol. 2024 Aug;25(8):1422-1431. doi: 10.1038/s41590-024-01890-1. Epub 2024 Jul 3. Nat Immunol. 2024. PMID: 38961274
-
Nardilysin-regulated scission mechanism activates polo-like kinase 3 to suppress the development of pancreatic cancer.Nat Commun. 2024 Apr 11;15(1):3149. doi: 10.1038/s41467-024-47242-3. Nat Commun. 2024. PMID: 38605037 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous